Virtual Apothecary

Biovista is a drug discovery and development company that leverages artificial intelligence and big data to identify new therapeutic uses for existing drugs and drug combinations. The company's core technology, the Virtual Apothecary platform, systematically maps the mechanism of action of drugs against the entire known clinical outcome space to predict efficacy and safety in new indications. Biovista's business model includes internal drug development programs, particularly in neurodegenerative and rare diseases, as well as strategic collaborations with pharmaceutical companies to de-risk and reposition their pipelines. By utilizing a non-obvious, data-driven approach, the company aims to significantly reduce the time and cost associated with traditional drug development.